Skip to the page

Data / Drug companies / Cohance Lifesciences Limited

Cohance Lifesciences Limited: 33 products in the FDA NDC directory, labeler code 68022

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Cohance Lifesciences Limited (labeler code 68022) lists 33 products in the FDA National Drug Code Directory. By type: 33 bulk ingredients. Its main marketing category is bulk ingredients for compounding. The newest product started marketing on January 9, 2024.

The request: Watch Cohance Lifesciences Limited (FDA labeler code 68022): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
68022
Products in commercial distribution
33
Packages
135
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Started marketing in the last 12 months
0
Earliest marketing start
February 2, 2016
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients for compounding2781.8%
Bulk ingredients618.2%

Products by type

TypeProductsShare
Bulk ingredients33100%

Dosage forms

Dosage formProductsShare
Powder33100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Iron sucrose complex68022-7032PowderBulk ingredients for compoundingJanuary 9, 2024
Sulfasalazine68022-7068PowderBulk ingredientsJanuary 1, 2024
Ferric carboxy maltose68022-7070PowderBulk ingredients for compoundingDecember 25, 2023
Methylene blue68022-7067PowderBulk ingredientsNovember 1, 2021
Isosulfan blue68022-7525PowderBulk ingredientsDecember 26, 2020
Danofloxacin mesylate68022-7524PowderBulk ingredientsDecember 26, 2020
Fluphenazine hydrochloride68022-7063PowderBulk ingredientsDecember 26, 2020
Probenecid68022-7061PowderBulk ingredientsDecember 26, 2020
L-carglumic acid68022-7523PowderBulk ingredients for compoundingDecember 26, 2018
Bretylium tosylate68022-7060PowderBulk ingredients for compoundingDecember 26, 2018
Edetate calcium disodium dihydrate68022-7059PowderBulk ingredients for compoundingDecember 26, 2018
Nitisinone68022-7058PowderBulk ingredients for compoundingDecember 26, 2018
Chloroquine phosphate68022-7057PowderBulk ingredients for compoundingDecember 26, 2018
Metyrosine68022-7056PowderBulk ingredients for compoundingDecember 26, 2018
Entacapone68022-7043PowderBulk ingredients for compoundingDecember 26, 2018
Calcium acetate68022-7025PowderBulk ingredients for compoundingFebruary 2, 2018
Carprofen68022-7010PowderBulk ingredients for compoundingDecember 20, 2017
Thiamine hydrochloride68022-7515PowderBulk ingredients for compoundingFebruary 2, 2016
Iron sucrose complex68022-7510PowderBulk ingredients for compoundingFebruary 2, 2016
Sodium ferric gluconate complex68022-7505PowderBulk ingredients for compoundingFebruary 2, 2016
Rifapentine68022-7055PowderBulk ingredients for compoundingFebruary 2, 2016
Glycopyrrolate tosylate68022-7054PowderBulk ingredients for compoundingFebruary 2, 2016
Trientine hydrochloride68022-7052PowderBulk ingredients for compoundingFebruary 2, 2016
Glycopyrrolate68022-7048PowderBulk ingredients for compoundingFebruary 2, 2016
Thiabendazole68022-7046PowderBulk ingredients for compoundingFebruary 2, 2016

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.